DIAGNOSTIC VALUE OF FUSION OF METABOLIC AND STRUCTURAL IMAGES FOR STEREOTACTIC BIOPSY OF BRAIN TUMORS WITHOUT ENHANCEMENT AFTER CONTRAST MEDIUM INJECTION.

Date publication

septembre 2019

Journal

Neuro-Chirurgie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NAMER Izzie-Jacques , Dr LHERMITTE Benoît , Dr CEBULA Hélène , Pr PROUST François , Dr BUND Caroline

Tous les auteurs :
Todeschi J, Bund C, Cebula H, Chibbaro S, Lhermitte B, Pin Y, Lefebvre F, Izzie JN, Proust F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31560911

Résumé

The heterogeneous nature of glioma makes it difficult to select a target for stereotactic biopsy that will be representative of grade severity on non-contrast-enhanced lesion imaging. The objective of this study was to evaluate the benefit of fusion of metabolic images (PET F-DOPA) with magnetic resonance imaging (MRI) morphological images for cerebral biopsy under stereotactic conditions of glioma without contrast enhancement.

Mots clés

(18)F-FDOPA PET, PET-MRI image registration, biopsy target, brain tumor, glioma target

Référence

Neurochirurgie. 2019 Sep 24;: